These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18957678)

  • 1. Refinement and psychometric evaluation of the impact of cancer scale.
    Crespi CM; Ganz PA; Petersen L; Castillo A; Caan B
    J Natl Cancer Inst; 2008 Nov; 100(21):1530-41. PubMed ID: 18957678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population.
    Blanchin M; Dauchy S; Cano A; Brédart A; Aaronson NK; Hardouin JB
    Health Qual Life Outcomes; 2015 Jul; 13():110. PubMed ID: 26220672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study.
    Oerlemans S; Smith SK; Crespi CM; Zimmerman S; van de Poll-Franse LV; Ganz PA
    Psychooncology; 2013 Jun; 22(6):1258-65. PubMed ID: 22833503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors.
    Crespi CM; Smith SK; Petersen L; Zimmerman S; Ganz PA
    J Cancer Surviv; 2010 Mar; 4(1):45-58. PubMed ID: 19967410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A procedure for obtaining impact of cancer version 2 scores using version 1 responses.
    Crespi CM; Ganz PA; Petersen L; Smith SK
    Qual Life Res; 2013 Feb; 22(1):103-9. PubMed ID: 22302619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivors.
    Alfano CM; McGregor BA; Kuniyuki A; Reeve BB; Bowen DJ; Wilder Smith A; Baumgartner KB; Bernstein L; Ballard-Barbash R; Malone KE; Ganz PA; McTiernan A
    Oncology; 2006; 70(3):190-202. PubMed ID: 16809938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Cancer Scale (IOC) in Italian long-term cancer survivors: adaptation and psychometric evaluation.
    Muzzatti B; Flaiban C; Romito F; Cormio C; Annunziata MA
    Support Care Cancer; 2013 Dec; 21(12):3355-62. PubMed ID: 23912670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors.
    Sarker SJ; Smith SK; Chowdhury K; Ganz PA; Zimmerman S; Gribben J; Korszun A
    Support Care Cancer; 2017 Mar; 25(3):739-748. PubMed ID: 27826873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric evaluation of the Impact of Cancer (IOC-CS) scale for young adult survivors of childhood cancer.
    Zebrack BJ; Donohue JE; Gurney JG; Chesler MA; Bhatia S; Landier W
    Qual Life Res; 2010 Mar; 19(2):207-18. PubMed ID: 20058086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of cancer: development of a new instrument for long-term survivors.
    Zebrack BJ; Ganz PA; Bernaards CA; Petersen L; Abraham L
    Psychooncology; 2006 May; 15(5):407-21. PubMed ID: 16097041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions.
    Reulen RC; Zeegers MP; Jenkinson C; Lancashire ER; Winter DL; Jenney ME; Hawkins MM
    Health Qual Life Outcomes; 2006 Oct; 4():77. PubMed ID: 17022814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric evaluation of the Persian version of the Lymphedema Life Impact Scale (LLIS, version 1) in breast cancer patients.
    Haghighat S; Montazeri A; Zayeri F; Ebrahimi M; Weiss J
    Health Qual Life Outcomes; 2018 Jun; 16(1):132. PubMed ID: 29954381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation, reliability and validity of the Spanish version of the Quality of Life in Adult Cancer Survivors (QLACS) questionnaire: application in a sample of short-term survivors.
    Escobar A; Trujillo-Martín Mdel M; Rueda A; Pérez-Ruiz E; Avis NE; Bilbao A
    Health Qual Life Outcomes; 2015 Nov; 13():182. PubMed ID: 26573805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors.
    Alfano CM; McGregor BA; Kuniyuki A; Reeve BB; Bowen DJ; Baumgartner KB; Bernstein L; Ballard-Barbash R; Malone KE; Ganz PA; McTiernan A
    Psychooncology; 2006 Nov; 15(11):985-1000. PubMed ID: 16470891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the quality of life in cancer survivors.
    Ferrell BR; Dow KH; Grant M
    Qual Life Res; 1995 Dec; 4(6):523-31. PubMed ID: 8556012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of quality of life instruments in long-term breast cancer survivors.
    Chopra I; Kamal KM
    Health Qual Life Outcomes; 2012 Jan; 10():14. PubMed ID: 22289425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding Application of the Long-Term Quality of Life Instrument to the Population of Women Undergoing Treatment of Advanced Breast Cancer.
    Kamp K; Flanigan M; Thana K; Terpstra J; Wyatt G; Sikorskii A
    Cancer Nurs; 2021 Mar-Apr 01; 44(2):E76-E82. PubMed ID: 31833917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors.
    Avis NE; Ip E; Foley KL
    Health Qual Life Outcomes; 2006 Dec; 4():92. PubMed ID: 17140438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an "Impact of HIV" Instrument for HIV Survivors.
    Buscher AL; Kallen MA; Suarez-Almazor ME; Giordano TP
    J Assoc Nurses AIDS Care; 2015; 26(6):720-31. PubMed ID: 26324524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Evaluation of a Korean Version of the Cancer Survivors' Self-efficacy Scale.
    Kim SH; Lee BG; Lee JY; Kim SJ; Hur MH; Lee MH; Han MS
    Cancer Nurs; 2019; 42(6):509-514. PubMed ID: 30601268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.